UB Paderborn / Katalog / Suche / in CDI

A Hexasaccharide Containing Rare 2‐O‐Sulfate‐Glucuronic Acid Residues Selectively Activates Heparin Cofactor II

Angewandte Chemie (International ed.), 2017-02, Vol.56 (9), p.2312-2317

International ed. in English, 2017

Volltextzugriff (PDF)

A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation

Molecular cancer therapeutics, 2019-01, Vol.18 (1), p.51-61

2019

Volltextzugriff (PDF)

Thermodynamic Affinity and Nature of Forces Defining Glycosaminoglycan-Protein Systems Using Fluorescence Spectroscopy

Methods in molecular biology (Clifton, N.J.), 2022, Vol.2303, p.259

2022

Volltextzugriff (PDF)

Studies on fragment-based design of allosteric inhibitors of human factor XIa

Bioorganic & medicinal chemistry, 2020-12, Vol.28 (23), p.115762-115762, Article 115762

2020

Volltextzugriff (PDF)

Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase

Oncotarget, 2016-12, Vol.7 (51), p.84608-84622

2016

Volltextzugriff (PDF)

Visualizing antithrombin-binding 3- O -sulfated heparan sulfate motifs on cell surfaces

Chemical communications (Cambridge, England), 2020-11, Vol.56 (92), p.14423-14426

2020

Volltextzugriff (PDF)

A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin

Bioorganic & medicinal chemistry letters, 2018-04, Vol.28 (6), p.1101-1105

2018

Volltextzugriff (PDF)

2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity

American journal of respiratory cell and molecular biology, 2017-01, Vol.56 (1), p.90-98

2017

Volltextzugriff (PDF)

A Hexasaccharide Containing Rare 2‐O‐Sulfate‐Glucuronic Acid Residues Selectively Activates Heparin Cofactor II

Angewandte Chemie, 2017-02, Vol.129 (9), p.2352-2357

2017

Volltextzugriff (PDF)

Chemoenzymatically Prepared Heparan Sulfate Containing Rare 2‑O-Sulfonated Glucuronic Acid Residues

ACS chemical biology, 2015-06, Vol.10 (6), p.1485-1494

2015

Volltextzugriff (PDF)

Interaction of Thrombin with Sucrose Octasulfate

Biochemistry (Easton), 2011-08, Vol.50 (32), p.6973-6982

2011

Volltextzugriff (PDF)

Abstract 3088: Identification of insulin-like growth factor 1 receptor as a novel and specific target of heparin hexasaccharide that selectively inhibits cancer stem cells

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.3088-3088

2021

Volltextzugriff (PDF)

Abstract 1166: Structurally defined glycosaminoglycan mimetics exhibit preference for proteins of the growth factor family

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1166-1166

2021

Volltextzugriff (PDF)

Glycosaminoglycan-protein interaction studies using fluorescence spectroscopy

Methods in molecular biology (Clifton, N.J.), 2015, Vol.1229, p.335

2015

Volltextzugriff (PDF)

Sa1196 - Steroidogenic Acute Regulatory Protein (Start) Related Lipid Transfer Domain Containing 5 (Stard5) is a Novel Target for Colon Cancer Stem Cells

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-274-S-274

2018

Volltextzugriff (PDF)

Abstract 6353: Cholesterol modification enhances potency and pharmacokinetic properties of a selective cancer stem cell targeting agent

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6353-6353

2020

Volltextzugriff (PDF)

Abstract 3460: p38-p14ARF-CtBP2 axis as a novel regulator of CSC phenotype and tumor cell dormancy

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3460-3460

2018

Volltextzugriff (PDF)

518 - G2.2, a Unique Non-Sachharide Mimetic of Heparin Hexasaccharide Selectively Inhibits Cancerous but Protects Adult Colonic Stem/Progenitor Cells via a Common Mechanism of Induction of P38 Mitogen-Activated Protein Kinase

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-114-S-115

2018

Volltextzugriff (PDF)

A Unique Non-Saccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation

Molecular cancer therapeutics, 2018-10, Vol.18 (1), p.51-61

2018

Volltextzugriff (PDF)

Visualizing antithrombin-binding 3--sulfated heparan sulfate motifs on cell surfaces

Chemical communications (Cambridge, England), 2020-11, Vol.56 (92), p.14423-14426

2020

Volltextzugriff (PDF)

S473 Changes in Tumor Micro-Environment With Liquid Nitrogen Spray Cryotherapy and Chemoradiation in Locally Advanced Esophageal Cancer

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e334-e335

2022

Volltextzugriff (PDF)

PHASE 1 DOSE-FREQUENCY ESCALATION STUDY OF NEOADJUVANT CRYOTHERAPY IN LOCALLY ADVANCED ESOPHAGEAL CANCER

Gastrointestinal endoscopy, 2023-06, Vol.97 (6), p.AB1020-AB1020

2023

Volltextzugriff (PDF)

PHASE 1 DOSE-FREQUENCY ESCALATION STUDY OF NEOADJUVANT CRYOTHERAPY IN LOCALLY ADVANCED ESOPHAGEAL CANCER

Gastrointestinal endoscopy, 2023-06, Vol.97 (6), p.AB1106-AB1107

2023

Volltextzugriff (PDF)

Abstract 4667: A synergistic combination strategy for optimal inhibition of colon cancer stem cells: Simultaneous inhibition of Insulin-like growth factor-1 receptor-AKT-mammalian target of rapamycin axis and the mevalonate-isoprenoid biosynthetic pathway

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4667-4667

2019

Volltextzugriff (PDF)

Abstract 2334: Non-Saccharide Glycosaminoglycan Mimetics Selectively Target Certain Receptor Tyrosine Kinases to Induce Anti-Cancer Stem Cell Activity

The Journal of biological chemistry, 2023, Vol.299 (3), p.103319, Article 103319

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A Hexasaccharide Containing Rare 2‐O‐Sulfate‐Glucuronic Acid Residues Selectively Activates Heparin Cofactor II

A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation

Thermodynamic Affinity and Nature of Forces Defining Glycosaminoglycan-Protein Systems Using Fluorescence Spectroscopy

Studies on fragment-based design of allosteric inhibitors of human factor XIa

Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase

Visualizing antithrombin-binding 3- O -sulfated heparan sulfate motifs on cell surfaces

A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin

2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity

A Hexasaccharide Containing Rare 2‐O‐Sulfate‐Glucuronic Acid Residues Selectively Activates Heparin Cofactor II

Chemoenzymatically Prepared Heparan Sulfate Containing Rare 2‑O-Sulfonated Glucuronic Acid Residues

Interaction of Thrombin with Sucrose Octasulfate

Abstract 3088: Identification of insulin-like growth factor 1 receptor as a novel and specific target of heparin hexasaccharide that selectively inhibits cancer stem cells

Abstract 1166: Structurally defined glycosaminoglycan mimetics exhibit preference for proteins of the growth factor family

Glycosaminoglycan-protein interaction studies using fluorescence spectroscopy

Sa1196 - Steroidogenic Acute Regulatory Protein (Start) Related Lipid Transfer Domain Containing 5 (Stard5) is a Novel Target for Colon Cancer Stem Cells

Abstract 6353: Cholesterol modification enhances potency and pharmacokinetic properties of a selective cancer stem cell targeting agent

Abstract 3460: p38-p14ARF-CtBP2 axis as a novel regulator of CSC phenotype and tumor cell dormancy

518 - G2.2, a Unique Non-Sachharide Mimetic of Heparin Hexasaccharide Selectively Inhibits Cancerous but Protects Adult Colonic Stem/Progenitor Cells via a Common Mechanism of Induction of P38 Mitogen-Activated Protein Kinase

A Unique Non-Saccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation

Visualizing antithrombin-binding 3--sulfated heparan sulfate motifs on cell surfaces

S473 Changes in Tumor Micro-Environment With Liquid Nitrogen Spray Cryotherapy and Chemoradiation in Locally Advanced Esophageal Cancer

PHASE 1 DOSE-FREQUENCY ESCALATION STUDY OF NEOADJUVANT CRYOTHERAPY IN LOCALLY ADVANCED ESOPHAGEAL CANCER

PHASE 1 DOSE-FREQUENCY ESCALATION STUDY OF NEOADJUVANT CRYOTHERAPY IN LOCALLY ADVANCED ESOPHAGEAL CANCER

Abstract 4667: A synergistic combination strategy for optimal inhibition of colon cancer stem cells: Simultaneous inhibition of Insulin-like growth factor-1 receptor-AKT-mammalian target of rapamycin axis and the mevalonate-isoprenoid biosynthetic pathway

Abstract 2334: Non-Saccharide Glycosaminoglycan Mimetics Selectively Target Certain Receptor Tyrosine Kinases to Induce Anti-Cancer Stem Cell Activity

Suchergebnisse filtern